Article
SHIP2: a "new" insulin pathway target for aging research.
Rejuvenation research - 1 Apr 2014
Accardi Giulia, Virruso Claudia, Balistreri Carmela Rita, Emanuele Fabrizio, Licastro Federico, Monastero Roberto, Porcellini Elisa, Vasto Sonya, Verga Salvatore, Caruso Calogero, Candore Giuseppina
Abstract excerpt
Strong evidence suggests that systemic inflammation and central adiposity contribute to and perpetuate metabolic syndrome. All of these alterations predispose individuals to type 2 diabetes mellitus (T2DM), cardiovascular disease, as well as Alzheimer's disease (AD), all characterized by chronic inflammatory status. On the other hand, extensive abnormalities in insulin and insulin-like growth factor I (IGF-I) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
